LY2951742
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LY2951742, covering 2018-11-08 to 2020-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY2951742 in Participants With Migraine [Phase 2]